Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Correction

Correction: Low-dose adropin stimulates inflammasome activation of macrophage via mitochondrial ROS involved in colorectal cancer progression

Authors: Linghui Jia, Liting Liao, Yongshuai Jiang, Xiangyu Hu, Guotao Lu, Weiming Xiao, Weijuan Gong, Xiaoqin Jia

Published in: BMC Cancer | Issue 1/2023

Login to get access

Excerpt

Correction: BMC Cancer 23, 1042 (2023) …
Literature
1.
Metadata
Title
Correction: Low-dose adropin stimulates inflammasome activation of macrophage via mitochondrial ROS involved in colorectal cancer progression
Authors
Linghui Jia
Liting Liao
Yongshuai Jiang
Xiangyu Hu
Guotao Lu
Weiming Xiao
Weijuan Gong
Xiaoqin Jia
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11611-w

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue

Research

Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma

Research

NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling

Research

A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer

Research

Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

Research

The impact of an online educational game on breast cancer awareness among university female students, Malaysia: a pilot study

Research

Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits